Skip to content
Screener

CVS Health CVS Restricted Cash Noncurrent

Restricted Cash Noncurrent at other companies

CVS Health logo
CVS HealthCVS
$208M+6.7%
Eos Energy Enterprises, Inc. logo
Eos Energy Enterprises, Inc.EOSE
$15M-51.8%
Clear Secure logo
Clear SecureYOU
$2.85M+2.8%
Intrepid Potash logo
Intrepid PotashIPI
$600K0.0%
Kymera Therapeutics logo
Kymera TherapeuticsKYMR
$5.82M0.0%
Circle Internet Group logo
Circle Internet GroupCRCL
$12.81M+299%

Other financials

Income statement

See full
Revenue$106.10B+7.3%
Gross profit$47.2B+5.2%
Operating income$4.7B+97.5%
Net income$3.0B+192%
EPS (diluted)$2.31+189%

Balance sheet

See full
Cash & equivalents$11.5B-4.1%
Total debt$74.3B+286%
Total equity$79.7B+3.0%
Total assets$253.77B-1.8%

Cash flow

See full
Operating cash flow$6.3B+234%
CapEx$691.0M+13.8%
Free cash flow$5.7B+338%

Valuation

See full
Market cap$122.36B+48.7%
Enterprise value$185.17B+107%
P/E25×+6.9×
P/S0.3×+0.1×

Profitability

See full
Gross margin44.5%-0.3pp
Operating margin2%-0.3pp
Net margin1.2%0.0pp
FCF margin2.8%—

Returns & leverage

See full
Return on equity6.2%+0.3pp
Debt / equity0.9×+0.7×
Current ratio0.9×+0.1×

Where this comes from

Reported directly by CVS Health in its filing.

Tagged under the XBRL concept us-gaap:RestrictedCashNoncurrent.

The source filing: CVS Health’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 6:33 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0000064803-26-000098
In millionsJune 30,2026December 31,2025
Cash and cash equivalents$11,329$8,453
Restricted cash (included in other current assets)—59
Restricted cash (included in other assets)208200
Total cash, cash equivalents and restricted cash in the statements of cash flows$11,537$8,712

Item 1.Financial Statements

FAQ

What is CVS Health's restricted cash noncurrent?
CVS Health (CVS) reported restricted cash noncurrent of $208M in Q2 2026.
How has CVS Health's restricted cash noncurrent changed year-over-year?
CVS Health's restricted cash noncurrent increased by 6.7% year-over-year, from $195M to $208M.
What is the long-term trend for CVS Health's restricted cash noncurrent?
Over 5 years (2020 to 2025), CVS Health's restricted cash noncurrent has grown at a -6.2% compound annual growth rate (CAGR), from $276M to $200M.
What does restricted cash noncurrent mean?
Restricted Cash Noncurrent as reported by CVS HEALTH CORPORATION.

Ask your AI about CVS Health's restricted cash noncurrent.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude